Siga Technologies (SIGA) Free Cash Flow Growth (3y) (2013 - 2025)
Siga Technologies (SIGA) Free Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 14.41% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 216.31% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 4.08% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 49.44% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -10.40% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -9.38% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 134.18% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Siga Technologies | 212.67 Mn | 57.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -28.33% |
| Jun 30, 2025 | 212.69% |
| Mar 31, 2025 | -50.12% |
| Dec 31, 2024 | 51.85% |
| Sep 30, 2024 | -87.08% |
| Jun 30, 2024 | 83.02% |
| Mar 31, 2024 | -8.27% |
| Dec 31, 2023 | 19.82% |
| Sep 30, 2023 | -29.32% |
| Jun 30, 2023 | 26.55% |
| Mar 31, 2023 | 94.81% |
| Dec 31, 2022 | 17.17% |
| Sep 30, 2022 | -144.63% |
| Jun 30, 2022 | 20.22% |
| Mar 31, 2022 | 4,997.96% |
| Dec 31, 2021 | 85.53% |
| Sep 30, 2021 | -73.37% |
| Jun 30, 2021 | 34.87% |
| Mar 31, 2021 | 17.43% |
| Dec 31, 2020 | 96.64% |